S&P 500   2,677.88 (+0.53%)
DOW   22,816.90 (+0.60%)
QQQ   197.14 (+0.34%)
AAPL   260.70 (-0.67%)
FB   168.48 (+1.77%)
MSFT   164.73 (-0.33%)
GOOGL   1,185.05 (+0.16%)
AMZN   2,011.46 (+0.69%)
CGC   14.40 (+0.42%)
NVDA   259.53 (-3.30%)
BABA   197.49 (+0.53%)
MU   46.71 (+0.73%)
GE   7.06 (-2.89%)
TSLA   544.43 (+5.46%)
AMD   47.73 (+0.42%)
T   30.18 (+2.51%)
ACB   0.80 (+0.00%)
F   4.71 (+2.84%)
NFLX   372.22 (-2.04%)
BAC   22.19 (+3.74%)
GILD   74.50 (-4.00%)
DIS   100.59 (+1.01%)
S&P 500   2,677.88 (+0.53%)
DOW   22,816.90 (+0.60%)
QQQ   197.14 (+0.34%)
AAPL   260.70 (-0.67%)
FB   168.48 (+1.77%)
MSFT   164.73 (-0.33%)
GOOGL   1,185.05 (+0.16%)
AMZN   2,011.46 (+0.69%)
CGC   14.40 (+0.42%)
NVDA   259.53 (-3.30%)
BABA   197.49 (+0.53%)
MU   46.71 (+0.73%)
GE   7.06 (-2.89%)
TSLA   544.43 (+5.46%)
AMD   47.73 (+0.42%)
T   30.18 (+2.51%)
ACB   0.80 (+0.00%)
F   4.71 (+2.84%)
NFLX   372.22 (-2.04%)
BAC   22.19 (+3.74%)
GILD   74.50 (-4.00%)
DIS   100.59 (+1.01%)
S&P 500   2,677.88 (+0.53%)
DOW   22,816.90 (+0.60%)
QQQ   197.14 (+0.34%)
AAPL   260.70 (-0.67%)
FB   168.48 (+1.77%)
MSFT   164.73 (-0.33%)
GOOGL   1,185.05 (+0.16%)
AMZN   2,011.46 (+0.69%)
CGC   14.40 (+0.42%)
NVDA   259.53 (-3.30%)
BABA   197.49 (+0.53%)
MU   46.71 (+0.73%)
GE   7.06 (-2.89%)
TSLA   544.43 (+5.46%)
AMD   47.73 (+0.42%)
T   30.18 (+2.51%)
ACB   0.80 (+0.00%)
F   4.71 (+2.84%)
NFLX   372.22 (-2.04%)
BAC   22.19 (+3.74%)
GILD   74.50 (-4.00%)
DIS   100.59 (+1.01%)
S&P 500   2,677.88 (+0.53%)
DOW   22,816.90 (+0.60%)
QQQ   197.14 (+0.34%)
AAPL   260.70 (-0.67%)
FB   168.48 (+1.77%)
MSFT   164.73 (-0.33%)
GOOGL   1,185.05 (+0.16%)
AMZN   2,011.46 (+0.69%)
CGC   14.40 (+0.42%)
NVDA   259.53 (-3.30%)
BABA   197.49 (+0.53%)
MU   46.71 (+0.73%)
GE   7.06 (-2.89%)
TSLA   544.43 (+5.46%)
AMD   47.73 (+0.42%)
T   30.18 (+2.51%)
ACB   0.80 (+0.00%)
F   4.71 (+2.84%)
NFLX   372.22 (-2.04%)
BAC   22.19 (+3.74%)
GILD   74.50 (-4.00%)
DIS   100.59 (+1.01%)
Log in

OTCMKTS:GNGBYGETINGE AB/ADR Stock Price, Forecast & News

$18.87
+0.37 (+2.00 %)
(As of 04/7/2020 03:43 PM ET)
Add
Compare
Today's Range
$18.72
Now: $18.87
$18.87
50-Day Range
$14.99
MA: $17.41
$19.63
52-Week Range
$11.62
Now: $18.87
$19.63
Volume7,626 shs
Average Volume17,923 shs
Market Capitalization$4.80 billion
P/E Ratio40.15
Dividend Yield0.37%
Beta0.97
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GNGBY
CUSIPN/A
CIKN/A
Phone46-1-033-500-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.81 billion
Cash Flow$1.64 per share
Book Value$8.15 per share

Profitability

Net Income$129.29 million

Miscellaneous

Employees12,000
Market Cap$4.80 billion
Next Earnings Date4/28/2020 (Estimated)
OptionableNot Optionable

Receive GNGBY News and Ratings via Email

Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter.


GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions

How has GETINGE AB/ADR's stock been impacted by COVID-19 (Coronavirus)?

GETINGE AB/ADR's stock was trading at $16.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GNGBY stock has increased by 15.8% and is now trading at $18.87. View which stocks have been mosted impacted by Coronavirus.

When is GETINGE AB/ADR's next earnings date?

GETINGE AB/ADR is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for GETINGE AB/ADR.

How were GETINGE AB/ADR's earnings last quarter?

GETINGE AB/ADR (OTCMKTS:GNGBY) released its quarterly earnings results on Friday, January, 31st. The company reported $0.40 earnings per share for the quarter. The firm earned $884.45 million during the quarter. GETINGE AB/ADR had a return on equity of 9.20% and a net margin of 4.54%. View GETINGE AB/ADR's earnings history.

Has GETINGE AB/ADR been receiving favorable news coverage?

Press coverage about GNGBY stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. GETINGE AB/ADR earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutGETINGE AB/ADR.

Who are some of GETINGE AB/ADR's key competitors?

What other stocks do shareholders of GETINGE AB/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GETINGE AB/ADR investors own include Immunomedics (IMMU), Oracle (ORCL), FOX (FOXA), Regeneron Pharmaceuticals (REGN), Skyworks Solutions (SWKS), United Continental (UAL), Alteryx (AYX), BP (BP), Boston Scientific (BSX) and Corelogic (CLGX).

Who are GETINGE AB/ADR's key executives?

GETINGE AB/ADR's management team includes the following people:
  • Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 47)
  • Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 47)
  • Lars Mattson, Head of Investor Relations
  • Ms. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 54)
  • Mr. Abraham Ronai, Gen. Counsel

What is GETINGE AB/ADR's stock symbol?

GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY."

How do I buy shares of GETINGE AB/ADR?

Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GETINGE AB/ADR's stock price today?

One share of GNGBY stock can currently be purchased for approximately $18.87.

How big of a company is GETINGE AB/ADR?

GETINGE AB/ADR has a market capitalization of $4.80 billion and generates $2.81 billion in revenue each year. GETINGE AB/ADR employs 12,000 workers across the globe. View additional information about GETINGE AB/ADR.

What is GETINGE AB/ADR's official website?

The official website for GETINGE AB/ADR is http://www.getinge.com/.

How can I contact GETINGE AB/ADR?

GETINGE AB/ADR's mailing address is LINDHOLMSPIREN 7, GOTHENBURG V7, 417 56. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected]

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel